ACXP
Acurx Pharmaceuticals, Inc.Company with tickers: ACXP
CIK
1736243
CUSIP
00510M203
Shares Outstanding
4,297,738
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $2,176,484 | USD | 2025-03-31 | 10-Q | 2026-05-11 |
| Research & Development | $598,798 | USD | 2025-03-31 | 10-Q | 2026-05-11 |
| Operating Income | $-2,176,484 | USD | 2025-03-31 | 10-Q | 2026-05-11 |
| Net Income | $-2,149,193 | USD | 2025-03-31 | 10-Q | 2026-05-11 |
| EPS (Basic) | $-2.15 | USD/shares | 2025-03-31 | 10-Q | 2026-05-11 |
| EPS (Diluted) | $-2.15 | USD/shares | 2025-03-31 | 10-Q | 2026-05-11 |